1. Home
  2. PROF vs LPCV Comparison

PROF vs LPCV Comparison

Compare PROF & LPCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$6.46

Market Cap

243.2M

Sector

Health Care

ML Signal

HOLD

LPCV

Launchpad Cadenza Acquisition Corp I Class A Ordinary Share

N/A

Current Price

$10.01

Market Cap

286.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
PROF
LPCV
Founded
N/A
2025
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
243.2M
286.6M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
PROF
LPCV
Price
$6.46
$10.01
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
65.9K
6.1K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
25.89
N/A
EPS
0.19
N/A
Revenue
$16,098,000.00
N/A
Revenue This Year
$92.40
N/A
Revenue Next Year
$64.10
N/A
P/E Ratio
$35.11
N/A
Revenue Growth
50.73
N/A
52 Week Low
$3.92
$9.89
52 Week High
$8.95
$10.03

Technical Indicators

Market Signals
Indicator
PROF
LPCV
Relative Strength Index (RSI) 41.47 66.64
Support Level $5.81 $9.89
Resistance Level $7.07 $10.03
Average True Range (ATR) 0.27 0.01
MACD -0.07 0.01
Stochastic Oscillator 15.15 100.00

Price Performance

Historical Comparison
PROF
LPCV

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

About LPCV Launchpad Cadenza Acquisition Corp I Class A Ordinary Share

Launchpad Cadenza Acquisition Corp I is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.

Share on Social Networks: